TA135: Mesothelioma - pemetrexed disodium
This is a discussion on TA135: Mesothelioma - pemetrexed disodium within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Mesothelioma - pemetrexed disodium. It links to the published guidance and key documents. ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA135: Mesothelioma - pemetrexed disodium
The summary for the published technology appraisal on Mesothelioma - pemetrexed disodium. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA124: Lung cancer (non-small-cell) - pemetrexed | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| New Guideline From NCCN on Mesothelioma | industry_news | Other Clinical Pharmacy News | 0 | 03-17-2010 12:21 PM |
| TA181: Lung cancer (non-small cell, first line treatment) - pemetrexed | industry_news | Updates from the Technology Assessment Authorities | 0 | 09-22-2009 08:06 PM |
| Drug Shortages: Current Drug Shortages: Calcium Disodium Versenate Injection 200 mg/mL 5 mL ampules(NDC 00089-0510-06) | industry_news | FDA News | 0 | 02-09-2009 04:45 PM |
| Pemetrexed Plus Cisplatin Has "Remarkable" Results in Mesothelioma | industry_news | Other Clinical Pharmacy News | 0 | 10-07-2008 11:37 AM |
© 2008 DrugManagementForum™ powered by |
 |